Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseGraft vs Host ReactionBone MarrowWhole-Body IrradiationBone Marrow CellsLeukemiaAnemia, AplasticTransplantation ConditioningGraft SurvivalTransplantation, AutologousTransplantation ChimeraGraft vs Tumor EffectBusulfanTissue DonorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukocyte TransfusionHistocompatibility TestingHematopoietic Stem Cell TransplantationGraft vs Leukemia EffectRecurrenceHistocompatibilityRadiation ChimeraLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaCyclophosphamideLymphocyte DepletionRemission InductionHematologic NeoplasmsTransplantation, IsogeneicAcute DiseaseBone and BonesLymphocyte TransfusionImmunosuppressive AgentsHepatic Veno-Occlusive DiseaseLeukemia, MyeloidMice, Inbred C57BLBone Marrow PurgingCombined Modality TherapyImmunosuppressionChimeraHematopoietic Stem CellsTime FactorsT-LymphocytesTreatment OutcomeLiver TransplantationMyelodysplastic SyndromesNuclear FamilyTransplantation ImmunologyCyclosporineHematopoiesisGraft RejectionSurvival AnalysisActuarial AnalysisHLA AntigensRetrospective StudiesCytomegalovirus InfectionsMice, Inbred BALB CHematologic DiseasesFatal OutcomeLymphoma, Non-HodgkinKidney TransplantationSevere Combined ImmunodeficiencyCytarabineSurvival RateBone Marrow DiseasesFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalSpleenPancytopeniaLeukocyte CountGranulocyte Colony-Stimulating FactorLeukemia, Myelomonocytic, AcuteAnemia, Refractory, with Excess of BlastsInfectionStem Cell TransplantationBone Marrow ExaminationMethotrexateLymphomaEtoposideNeoplasm, ResidualCyclosporinsImmunocompromised HostAntilymphocyte SerumFlow CytometryGanciclovirMultiple MyelomaHeart TransplantationPrognosisBone RemodelingMice, Inbred C3HLife TablesMice, Inbred AKRImmunophenotypingColony-Forming Units AssayIsoantigensCytogeneticsPneumonia, Viral